Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Larimar Therapeutics Inc. buy melinda

Start price
€64.73
14.03.16 / 50%
Target price
€81.18
04.04.16
Performance (%)
26.76%
End price
€82.05
04.04.16
Summary
This prediction ended on 04.04.16 with a price of €82.05. The prediction had a final performance of 26.76%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Larimar Therapeutics Inc. 5.732% 5.732% -57.868% -84.209%
iShares Core DAX® 4.594% -1.689% 18.502% 45.137%
iShares Nasdaq 100 1.678% 2.390% 39.942% 145.307%
iShares Nikkei 225® 4.303% -0.265% 7.459% 36.306%
iShares S&P 500 3.299% 2.699% 38.349% 88.501%

According to melinda what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Zafgen Inc. diskutieren
Prediction Buy
Perf. (%) 26.76%
Target price 6.765
Change
Ends at 04.04.16

obesité sévére

données le 31/03/2016

Prediction Buy
Perf. (%) 26.76%
Target price 6.765
Change
Ends at 04.04.16

(Zielkurs erreicht)

Stopped prediction by melinda for Larimar Therapeutics Inc.

buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.94
10.12.19
€13.00
04.11.21
20.81%
05.11.21

Could be worthwhile Investment >10% per year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€54.88
07.02.19
€97.42
13.02.19
-11.83%
13.02.19

Could be worthwhile Investment >10% per year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€87.46
08.03.18
€97.42
25.06.18
16.58%
25.06.18

Could be worthwhile Investment >10% per year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€44.92
13.05.17
€54.12
14.11.17
-12.05%
14.11.17

Could be worthwhile Investment >10% per year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€78.15
07.04.16
€184.01
21.07.16
-54.46%
21.07.16

Could be worthwhile Investment >10% per year